Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Soluble CD83 speeds up wound healing and reduces scarring.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

CXCR2 in skin cells promotes tumor growth.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

CCCA may be caused by both hair traction and an immune response.

CD200- cells in hair follicles have a higher ability to regenerate hair.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Arab APS1 patients have unique and recurrent AIRE gene mutations.